Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venetoclax-Dexamethasone in Relapsed/Refractory t(11;14) AL Amyloidosis
NCT05451771Phase 2Active, not recruiting
- Sponsor
- Columbia University
- Start
- Oct 2022
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of venetoclax in amyloid light chain amyloidosis, sponsored by Columbia University. Started Oct 2022; status: active, not recruiting.
02
Drugs
venetoclax
03
Conditions
amyloid light chain amyloidosis
Beyond the preview
Go deeper on NCT05451771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05451771.